AI-assisted medical care: the right-hand man of future doctors, or a cold substitute for human care?
Release time:
Oct 20,2025
One day you feel unwell, but you don't need to line up for registration and wait for diagnosis, because your personal AI health assistant has monitored the abnormality and analyzed the condition and recommended treatment options for you in advance.
One day you feel unwell, but you don't need to line up for registration and wait for diagnosis, because your personal AI health assistant has monitored the abnormality and analyzed the condition and recommended treatment options for you in advance.This is not a plot of science fiction, but a real picture of technological change.From September 27th to 28th, U.S. West Time, Stanford University's NEX-T Summit2025 realized such a brainstorming, focusing on the impact of future technologies on medical care.From genomic research to diagnosis and treatment, from drug research and development to personalized health management, technology giants in the field have brought unprecedented perspectives and stories.This summit not only caused a sensation in Silicon Valley, but also provided important inspiration for the transformation of the medical industry in China and even the world.But can AI really change the future of medical care?Or is it just a gimmick of hype?The suspense is here, and we patiently unravel the clues.
The optimists of science and technology and the cautious of reality have set off a clash of views around the role of AI in medical care.At the summit, Michael Schneider showed great enthusiasm for the potential of AI. He believes that AI has played a revolutionary role in four aspects: research, diagnosis, treatment, and patient management.For example, genetic research in the past was like finding a needle in a haystack, but now AI is like a fisherman who throws a net accurately, able to screen out pathogenic genes on the order of a hundredfold of traditional methods.This not only improves research efficiency, but also paves the way for early detection of diseases.On the contrary, Sanjiv Kumar reminded everyone that the actual limitations of AI are still obvious, such as the needs in the clinical stage, which involves complex and demanding data processing and cannot be achieved overnight by relying on technology.Whether it is to advance by leaps and bounds or step by step, the answer to this debate does not seem to be simple.
Let us discuss in depth from all points of view.There is a supporting basis for Michael Schneider's optimism. He mentioned that an AI-led early disease detection system can issue risk warnings before people become ill.For ordinary people, this is a dazzling story. For example, you have a family history of high blood pressure since you were a child, and you are still asymptomatic every day. Relying on AI testing, you can find signs in advance, just like a health detective who is always on guard.Another guest, Michelle Chen, revealed that in the field of drug research and development, although AI has improved efficiency, it can still only be slightly improved in the clinical trial stage.This is like driving fast with an accelerator, but once you encounter complex terrain, no matter how good the accelerator is, you can't get rid of the mud.The guests also mentioned that when doctors and AI work together to deal with patients, technology does reduce the rate of misdiagnosis, but it can never replace the humanistic care of doctors.If your family is seriously ill, would you be willing to face the cold machine?Or is it a warm doctor who needs more detailed answers to the condition?This contrast makes the problem closer to life.
Latest News
Contact Info
Add: No.888, Tourism Avenue, Taierzhuang District, Zaozhuang City, Shandong, 277400 China
Tel: +86-632-6626 259
Whatsapp: 0041 78212 5057
Wechat: 15953541628
Mailbox: info@qsen.com
Powered by : www.300.cn